Sunday, September 6, 2026

AI Infrastructure Crisis: How Google’s Limit on Meta’s Gemini Model Highlights a Global Computing Bottleneck

Google limits Meta's AI model access due to computing shortages, impacting key projects and shifting focus to efficiency in AI usage.

OCI Holdings Launches 394 Million USD Solar Power Project in Texas: What You Need to Know

OCI Holdings boosts AI investments in the U.S. with a solar project, securing $394M financing for a 260MW facility in Texas.

AI Medical Revolution: Waycen Partners with Dhafir Medical to Launch Waymed Endo in UAE

Waycen partners with Dhafir Medical to introduce AI endoscope in the UAE, enhancing healthcare training and expanding market presence.

Dae Hyeon Moon

Author's Latest

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Mediwhale’s DrNoon Receives CE MDR Certification in Europe for Cardiovascular Risk Prediction

Mediwheel's retinal AI solution 'DrNoon' has received CE MDR certification, enhancing its credibility in the European medical device market.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

AITRICS: “Medical Artificial Intelligence (AI) is No Longer a Choice”

Medical AI must prove its real-world value. AITRICS focuses on tools that enhance decision-making and integrate into healthcare workflows.

i-SENS CareSens Air 2: The Future of Blood Sugar Monitoring in 2026

i-SENS is expanding globally with the CareSens Air 2, enhancing digital features for better diabetes management and market competitiveness.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Microgravity in Space May Revolutionize How Biopharmaceuticals Form and Function within the Body

Space's microgravity could transform biopharmaceuticals, enabling new treatments and technologies for diseases, emphasizing long-term research.

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

Dong-A University Hospital Launches AI-Driven thynC Monitoring System

Dong-A University Hospital launches AI-powered smart bed system thynC, enhancing patient monitoring and safety across general wards.

Discover the Breakthroughs of Korea’s ARPA-H Project: 5 Key Missions for Health Security and Innovation

The K-Health Future Promotion Team showcased interim results of the Korean ARPA-H project at Bio Korea 2026, focusing on innovative healthcare solutions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.